“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior employees scientist while in the Bohn lab. “This is the fascinating aspect for opportunity use while in the context of chronic, significant pain.” https://howardq370jry4.wikijm.com/user